Decision aid to support choices for coronary artery anomalies
Official title: Development of a Shared Decision Aid for Anomalous Aortic Origin of a Coronary Artery
Run by Vanderbilt University Medical Center · NCT07544979 · Data updated 2026-11-12
This study tests a decision aid to help English-speaking patients 10-35 and their families weigh management options for R-AAOCA without ischemia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 10 Years to 35 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 5 sites (Boston, Massachusetts and 4 other locations) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | March 30, 2029 |
| Study ends | March 30, 2029 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT07544979 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking patients aged 10-35 with R-AAOCA without myocardial ischemia and their English-speaking parents/caregivers, without other significant cardiac conditions.
✕Probably not a fit
Patients with non-English language needs or those with additional major cardiac anomalies may not benefit from this SDM-focused tool.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study focuses on developing and testing a decision aid to support shared decision making for patients with right coronary artery anomalies originating from the left side. The tool is designed to present evidence and help align treatment choices with patient and family values. The study includes qualitative input from patients, parents, and clinicians to identify key decision factors and to assess how the aid influences discussions and confidence in choices. It is conducted across multiple pediatric and academic centers in the United States.
Why it matters
Potential benefit: If successful, the tool could reduce anxiety and improve satisfaction with the management decision by clarifying risks and options.
How similar studies have gone: Previous SDM and decision aids in cardiology have shown improvements in knowledge and satisfaction, supporting potential benefit for this application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients * English-speaking * 10-35 years of age * Diagnosis of R-AAOCA without evidence of myocardial ischemia Parents * English-speaking * Child 10-17 years of age * Diagnosis of R-AAOCA without evidence of myocardial ischemia Exclusion Criteria: * Patients * Other significant cardiac anomalies * Unwilling or unable to provide consent * Non-English Speaking Parents * Child with other significant cardiac anomalies * Unwilling or unable to provide consent * Non-English Speaking
Where it's running
-
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting -
Boston Children's Hospital
Boston, Massachusetts, United States Not yet recruiting -
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States Not yet recruiting -
Dell Children's Medical Center
Austin, Texas, United States Not yet recruiting -
Texas Children's Hospital
Houston, Texas, United States Not yet recruiting
Study contacts
- Study coordinator: Andrew M Well, MD, MPH, MSHCT
- Email: andrew.well@vumc.org
- Phone: 615-343-0042
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving diagnosis of anomalous coronary arteries
This study is testing a new online tool that uses advanced technology to help doctors better diagnose and understand the risks for patients with unusual heart artery conditions.
-
Parasite and Infestation Experience: Understanding What People Feel and Think
This observational study tests how people who strongly believe they have parasites or infestation feel and think, even when doctors say otherwise.
-
Corticosteroid for Diabetic Macular Edema (DME) in Adults with Diabetic Retinopathy
This trial tests whether intravitreal corticosteroid injections can influence inflammatory biomarkers and improve DME in adults with type 2 diabetes.
-
Non-invasive test to predict early heart rejection in pediatric transplant patients
This study tests non-invasive heart tests like cardiac MRI and blood markers to see if they can detect rejection in kids after heart transplant, potentially reducing the need for invasive biopsies.
-
AR-guided resection planning for head and neck tumors
Aims to see if augmented reality guidance can help surgeons perform more precise re-sections in head and neck tumor cases using cadaver specimens.
-
Modeling heart failure in Duchenne and Becker muscular dystrophy to find surrogate heart measures
This study will look at heart disease in people with Duchenne/Becker muscular dystrophy and carriers to see if MRI-based heart measures can predict death or major heart problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.